MorphoSys AG logo
MorphoSys AG MOR

Annual report 2023
added 12-27-2025

report update icon

MorphoSys AG P/S Ratio 2011-2026 | MOR

Annual P/S Ratio MorphoSys AG

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 1.75 10.9 62.9 41.5 - - - - - - -

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
62.9 1.75 29.3

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
AbbVie AbbVie
ABBV
24.1 $ 208.84 -2.86 % $ 369 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
12.8 $ 3.52 0.28 % $ 1.05 B canadaCanada
Grifols, S.A. Grifols, S.A.
GRFS
1.71 $ 8.24 -0.12 % $ 6.83 B spainSpain
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
947 $ 229.25 0.44 % $ 5 B danmarkDanmark
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
1.95 $ 74.21 -2.3 % $ 1.43 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.27 $ 1.41 2.17 % $ 375 M britainBritain
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
47.2 $ 1.51 48.04 % $ 17 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
3.63 $ 55.5 -3.04 % $ 10.6 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
2.65 $ 8.03 2.29 % $ 220 M israelIsrael
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
8.96 $ 14.81 2.63 % $ 2.25 B usaUSA
Altimmune Altimmune
ALT
7.76 K $ 3.34 7.05 % $ 294 M usaUSA
BioNTech SE BioNTech SE
BNTX
35.7 $ 91.18 1.97 % $ 27.2 B germanyGermany
Amgen Amgen
AMGN
5.4 $ 347.94 -1.51 % $ 187 B usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
24.1 $ 15.61 0.9 % $ 2.1 B canadaCanada
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
2.54 $ 59.6 -2.45 % $ 121 B usaUSA
Aptinyx Aptinyx
APTX
204 - -39.0 % $ 4.57 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
6.35 $ 4.14 -2.59 % $ 683 M britainBritain
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
3.81 $ 9.02 -3.84 % $ 1.86 B usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
2.11 $ 5.76 1.95 % $ 469 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
Cellectis S.A. Cellectis S.A.
CLLS
6.69 $ 3.41 1.19 % $ 116 M franceFrance
Biogen Biogen
BIIB
2.97 $ 177.34 -3.5 % $ 26 B usaUSA
Axon Enterprise Axon Enterprise
AXON
19.1 $ 412.81 -2.54 % $ 31.3 B usaUSA